4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001104659-26-120789
Director bought 969,480 shares at $21.00 ($20,359,080)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2026-10-28 | Purchase | +952,380 | $21.00 | $19,999,980 | 2,815,707 | I |
| HEALY JAMES Director | 2026-10-28 | Purchase | +6,395 | $21.00 | $134,295 | 17,990 | I |
| HEALY JAMES Director | 2026-10-28 | Purchase | +3,772 | $21.00 | $79,212 | 14,924 | I |
| HEALY JAMES Director | 2026-10-28 | Purchase | +6,933 | $21.00 | $145,593 | 25,267 | I |
| Open-market purchases · 969,480 sh · avg $21.00 · $20,359,080 | |||||||
Loading xslF345X06/tm2628672-1_4seq1.xml…